March 28, 2008
Implantable Device Designed For Type-2 Diabetes Patients Who Are Overweight And Do Not Respond To Current Oral Anti-Diabetic Treatments
ADVERTISEMENTS
New York-Presbyterian Hospital/Weill Cornell Medical Center is recruiting patients for a national clinical research study of an investigational implantable device designed to help those with type-2 diabetes who are overweight and do not respond to current oral anti-diabetic treatments. The Tantalus® System is designed to sense naturally occurring electrical activity of the stomach in real time and automatically apply electrical stimulation when a person eats.
Spread the word
Leave a Comment